Zelnick Kaufman Beth bought CRMD

September 9, 2025 · Form 4 insider transaction

Zelnick Kaufman Beth bought 50,000 shares of CorMedix Inc. at $3.30 per share, a transaction worth $165.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
50,000
Price
$3.30
Total value
$165.0K
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 9, 2025
Filing dateSeptember 11, 2025
Shares owned after230,418
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR